FDA Import Refusal AEK-8216980-4/11/1 — GLAXOSMITHKLINE
The FDA refused shipment AEK-8216980-4/11/1 from GLAXOSMITHKLINE (Canada) on Feb 18, 2025. The refused product falls under Drugs and Biologics — BELIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 18, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58MCY20 BELIMUMAB
- Charges
- 75